Carisoprodol 62135-0241-12
- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIV
- Marketing Start
- August 8, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA040245
Active Ingredients
| Ingredient | Strength |
|---|---|
| Carisoprodol | 350 mg/1 |
Drug Class
Muscle Relaxant [EPC]Centrally-mediated Muscle Relaxation [PE]Muscle Relaxant [EPC]
Selected Package
62135-0241-12Selected120 TABLET in 1 BOTTLE (62135-241-12)